Skip to main content
Nirmal Kaur, MD, Gastroenterology, Novi, MI

NirmalKaurMD

Gastroenterology Novi, MI

Inflammatory Bowel Disease

President & CEO, Syncoro Health L.L.C.

Dr. Kaur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kaur's full profile

Already have an account?

  • Office

    39450 Twelve Mile Road
    Novi, MI 48377
    Phone+1 716-390-2646

Summary

  • Dr. Nirmal Kaur is a gastroenterologist in Detroit, MI and is affiliated with Henry Ford Hospital. She received her medical degree from University at Buffalo, completed residency and fellowship at the University of Michigan, and has been in practice 13 years. She specializes in inflammatory bowel disease and is experienced in clinical trials, program development, and physician outreach.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Gastroenterology, 2007 - 2010
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 2004 - 2007
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2004
  • State University of New York at Buffalo
    State University of New York at BuffaloB.S., Bochemistry (Honors Program), Summa Cum Laude, 1996 - 2000

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2004 - 2027
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Physician Leadership Institute Certification Henry Ford Health, 2019
  • Top Doc Award Hour Detroit, 2013-2014, 2016-2017
  • MD Content Certification Henry Ford Health, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Fecal Microbiota Transplantation for the Treatment of Recurrent and Severe Clostridium Difficile Infection in Solid Organ Transplant Recipients: A Multicenter Experience  
    Raj Vuppalanchi, Adam Ehrlich, Michael Smith, Asif Sharfuddin, Nasia Safdar, Nirmal Kaur, Elizabeth Ann Misch, Monika Fischer, Ann Flynn, Vincent Ganapini, Michael H W..., American journal of transplantation
  • Liver Enzymes Elevate With Biologic Therapy for IBD  
    Kaur N, Gastroenterology, 1/6/2015
  • Iron Pill Gastropathy: A Case Report and Review of the Literature  
    Kaur N, Coffing BN, Greenson J, Chey WD, The American Journal of Gastroenterology, 1/1/2007

Abstracts/Posters

  • Inflammatory Bowel Disease Activity in Patients Undergoing Liver Transplant for Primary Sclerosing Cholangitis.
    Parekh RA, Kaur N, Digestive Disease Week, 1/21/2016
  • Tumor-Necrosis-Factor-alpha Antagonist Therapy for Inflammatory Bowel Disease After Liver Transplantation.
    Parekh RA, Kaur N, American Transplant Congress, 1/1/2016
  • Interferon-gamma release assay for latent tuberculosis is more frequently indeterminate in patients with inflammatory bowel disease.
    Mittal C, Kaur N, Crohn's and Colitis Foundation of America Advances in IBD Conference, 1/1/2013
  • Join now to see all

Lectures

  • Update in IBD 
    1/10/2016
  • Standard of Care Therapy in IBD 
    1/9/2016
  • Common Questions in IBD 
    1/24/2015
  • Join now to see all

Other

  • The Indigenous Gastrointestinal Microbiota in Health and Disease. 
    Kaur N, Kao JY, Young VB, Cyberrounds, Albert Einstein College of Medicine Continuing Medical Education
    http://www.cyberounds.com/content/new
    1/1/2010
  • Psychiatry and the Law: A Central European Perspective. 
    Kaur N, Halbreich U, International Society for PsychoNeuroEndocrinology Press, World Health Organization
    1/1/1999

Press Mentions

  • New Henry Ford Medical Center-Saginaw Boosts Access to Specialized Care for Mid-Michigan Patients
    New Henry Ford Medical Center-Saginaw Boosts Access to Specialized Care for Mid-Michigan PatientsSeptember 15th, 2021

Grant Support

  • Phase III Clinical TrialsNumerous2011–Present
  • Bridging Disparities in Healthcare Outcomes in IBD Using TelemedicinePfizer2022–2023

Professional Memberships